O’Melveny Worldwide

Qianyu Hu advises on a wide range of capital market transactions, primarily representing issuers and underwriters in initial public offerings. Qianyu also has experience in other equity offerings, such as private placings and rights issues, mergers and acquisitions and other general corporate law matters.

Prior to joining O’Melveny, Qianyu worked in the Hong Kong office of another international law firm.

  • Laopu Gold (6181.HK) in its approximately US$116 million IPO and listing on the Hong Kong Stock Exchange
  • Qunabox Group (0917.HK) in its approximately US$63 million IPO and listing on the Hong Kong Stock Exchange
  • CICC as the sole sponsor and overall coordinator in the approximately US$31 million IPO of Qyuns Therapeutics Co., Ltd. (2509.HK) on the Hong Kong Stock Exchange
  • Beijing UBOX Online Technology Corp. (2429.HK) in its approximately US$30 million IPO and listing on the Hong Kong Stock Exchange, marking the first Hong Kong listing of a company in the unmanned retail industry
  • Tiantu Capital (1973.HK) in its approximately US$144 million IPO and listing on the Hong Kong Stock Exchange, marking the first-ever listing of a PRC VC firm in Hong Kong
  • CICC, CCB, CMB, CMS and other underwriters in the approximately US$150 million IPO of Beijing Fourth Paradigm Technology Co., Ltd. (6682.HK) on the Hong Kong Stock Exchange
  • Beauty Farm Medical and Health Industry Inc. in its approximately US$100 million IPO and listing on the Hong Kong Stock Exchange
  • 3D Medicines Inc. in its US$52 million IPO and listing on the Hong Kong Stock Exchange
  • Gaush Meditech Ltd. in its US$86 million IPO and listing on the Hong Kong Stock Exchange
  • Haitong International Capital Limited and CCB International Capital Limited as joint sponsors, and other underwriters in the IPO and listing of Huafang Group Inc. on the Hong Kong Stock Exchange
  • ABCI Captial Limited, CICC Hong Kong Securities Limited and other underwriters in the H-share IPO of Lushang Life Services Co., Ltd (2376.HK) on the Hong Kong Stock Exchange
  • Gushengtang Holdings Limited in its US$104 million IPO and listing on the Hong Kong Stock Exchange
  • Goldman Sachs (Asia) L.L.C. and China International Capital Corporation Hong Kong Securities Limited and other underwriters in the US$145 million IPO and listing of Shanghai HeartCare Medical Technology Corporation Limited on the Hong Kong Stock Exchange
  • CCB International Capital Limited as sole sponsor and other underwriters in the approximately US$85 million IPO and listing of Kangqiao Service Group Limited on the Hong Kong Stock Exchange
  • BNP Paribas, China Construction Bank International, Industrial and Commercial Bank of China International and other underwriters in the spin-off and approximately US$126 million listing of Central China Management Company Limited on the Hong Kong Stock Exchange
  • J.P. Morgan, BofA Securities, CICC and Haitong International as joint sponsors and other underwriters in the approximately US$1.67 billion secondary listing of GDS Holdings Limited on the Hong Kong Stock Exchange
  • Simcere Pharmaceutical Group Limited in its US$461 million IPO and listing on the Hong Kong Stock Exchange
  • Hygeia Healthcare Holdings Co., Limited in its US$286 million IPO and listing on the Hong Kong Stock Exchange
  • Akeso Biopharma in its US$383 million IPO and listing on the Hong Kong Stock Exchange
  • Guotai Junan Capital as sole sponsor and Guotai Junan Securities (Hong Kong) as main underwriter, and other underwriters in the US$65 million IPO and listing of Zhongguancun Science-Tech Leasing on the Hong Kong Stock Exchange
  • Redsun Properties Group in its US$234 million initial public offering on the Main Board of the Hong Kong Stock Exchange
  • Jiangxi Bank in its US$952 million initial public offering on the Main Board of the Hong Kong Stock Exchange
  • CMBI, CCBI, Huatai, Guotai Junan and BOCI as underwriters in the US$761 million initial public offering of Bank of Gansu on the Main Board of the Hong Kong Stock Exchange
  • Morgan Stanley, HSBC and Citi as underwriters in the US$491 million initial public offering of Crystal Group, a Hong Kong apparel manufacturer, on the Main Board of the Hong Kong Stock Exchange
  • Morgan Stanley and CMBI as underwriters in the US$149 million initial public offering of Bestway Global, an outdoor leisure product manufacturer in China, on the Main Board of the Hong Kong Stock Exchange
  • BAML, CICC, BOCI and CMS as underwriters in the US$102 million initial public offering of New Century Healthcare, a leading pediatric healthcare provider in China, on the Main Board of the Hong Kong Stock Exchange
  • Morgan Stanley, Credit Suisse and CMS as underwriters in the US$322 million initial public offering of Zhou Hei Ya, a well-known braised food brand in China, on the Main Board of the Hong Kong Stock Exchange
  • Morgan Stanley and Nomura as underwriters in the US$172 million initial public offering of Honma Golf, a luxury golf equipment and accessory manufacturer, on the Main Board of the Hong Kong Stock Exchange
  • CICC, Macquarie, DBS and CMS as underwriters in the US$110 million IPO of Yihai International, a leading compound condiment manufacturer in China, on the Main Board of the Hong Kong Stock Exchange
  • Yadea Group Holdings Limited, a leading electric car manufacturer in China, in its US$166 million initial public offering on the Main Board of the Hong Kong Stock Exchange
  • Ronshine China, a leading property developer in China, in its US$230 million initial public offering on the Main Board of the Hong Kong Stock Exchange
  • China Galaxy as sponsor and other placing agents in LVGEM (China) Real Estate’s very substantial acquisition and US$225 million reverse takeover involving a deemed new listing application 
  • CMBI as joint underwriter, joint global coordinator, joint bookrunner and financial advisor in the US$1.5 billion rights issue of Fosun International
  • Morgan Stanley and CCBI as underwriters in the US$250 million initial public offering of Harmonicare Medical, a leading obstetrics and gynecology hospital group in China, on the Main Board of the Hong Kong Stock Exchange
  • BOCOM International and Macquarie as sponsors in the US$178 million initial public offering of Wuzhou International, a property developer and management company in China, on the Main Board of the Hong Kong Stock Exchange
  • Morgan Stanley, BNP Paribas, CICC, Standard Chartered, CCBI and HSBC as underwriters in the US$398 million initial public offering of Chinalco Mining Corporation International, a subsidiary of state-owned Aluminum Corporation of China, on the Main Board of the Hong Kong Stock Exchange
  • UBS, HSBC and BOCOM as underwriters in the US$215 million initial public offering of Yongda Auto, a leading premium car 4S dealership operator in China, on the Main Board of the Hong Kong Stock Exchange
  • Deutsche Bank, BOCI, BOCOM and CCBI as underwriters in the US$124 million initial public offering of China Tianrui Group Cement, a leading clinker and cement producer in China, on the Main Board of the Hong Kong Stock Exchange

Languages

  • Mandarin Chinese

Admissions

Bar Admissions

  • New York
  • Hong Kong (Registered Foreign Lawyer)

Education

  • Fordham University School of Law, LL.M.
  • University of Hong Kong, Master of Common Law
  • East China University of Political Science and Law, LL.B.